# IAL vs PS for Anterior Shoulder Dislocations

> **NCT03625076** · PHASE4 · UNKNOWN · sponsor: **Kendall Healthcare Group, Ltd.** · enrollment: 70 (estimated)

## Conditions studied

- Shoulder Dislocation

## Interventions

- **DRUG:** Intra-articular Lidocaine
- **DRUG:** Procedural Sedation with etomidate or propofol

## Key facts

- **NCT ID:** NCT03625076
- **Lead sponsor:** Kendall Healthcare Group, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2020-05-02
- **Final completion:** 2020-06-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2019-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03625076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03625076, "IAL vs PS for Anterior Shoulder Dislocations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03625076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*